Calcium-Activated-Calcineurin Reduces the In Vitro and In Vivo Sensitivity of Fluconazole to Candida albicans via Rta2p

Proteomic Analysis of Rta2p-Dependent Raft-Association of Detergent-Resistant Membranes in Candida albicans

(2012) Lin Wang et al.   PLoS One

Identification of a Cryptococcus neoformans Cytochrome P450 Lanosterol 14α-Demethylase (Erg11) Residue Critical for Differential Susceptibility between Fluconazole/Voriconazole and Itraconazole/Posaconazole

(2011) Edward Sionov et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Candida species bloodstream infection: epidemiology and outcome in a single institution from 1991 to 2008

(2011) M. Ortega et al.   JOURNAL OF HOSPITAL INFECTION

Calcineurin Signaling and Membrane Lipid Homeostasis Regulates Iron Mediated MultiDrug Resistance Mechanisms in Candida albicans

(2011) Saif Hameed et al.   PLoS One

Epidemiology, Species Distribution, Antifungal Susceptibility and Outcome of Nosocomial Candidemia in a Tertiary Care Hospital in Italy

(2011) Matteo Bassetti et al.   PLoS One

Fungal bloodstream infections in tertiary care hospitals in Colombia

(2011) Jorge Alberto Cortés et al.   REVISTA IBEROAMERICANA DE MICOLOGIA

Mechanism of the Synergistic Effect of Amiodarone and Fluconazole in Candida albicans

(2010) S. Gamarra et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Current therapeutic approaches to fungal infections in immunocompromised hematological patients

(2010) Livio Pagano et al.   BLOOD REVIEWS

Candidemia in children

(2010) Theoklis Zaoutis   CURRENT MEDICAL RESEARCH AND OPINION

Epidemiology of oral yeast colonization and infection in patients with hematological malignancies, head neck and solid tumors

(2010) Silke Schelenz et al.   JOURNAL OF ORAL PATHOLOGY & MEDICINE

Requirement for Ergosterol in V-ATPase Function Underlies Antifungal Activity of Azole Drugs

(2010) Yong-Qiang Zhang et al.   PLoS Pathogens

Reverse Genetics in Candida albicans Predicts ARF Cycling Is Essential for Drug Resistance and Virulence

(2010) Elias Epp et al.   PLoS Pathogens

Epidemiology and Outcomes of Candidemia in 2019 Patients: Data from the Prospective Antifungal Therapy Alliance Registry

(2009) David L. Horn et al.   CLINICAL INFECTIOUS DISEASES

Efflux-Mediated Antifungal Drug Resistance

(2009) R. D. Cannon et al.   CLINICAL MICROBIOLOGY REVIEWS

Excess mortality, length of stay and cost attributable to candidaemia

(2009) I. Hassan et al.   JOURNAL OF INFECTION

Harnessing Hsp90 function as a powerful, broadly effective therapeutic strategy for fungal infectious disease

(2009) Leah E. Cowen et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Hsp90 Orchestrates Stress Response Signaling Governing Fungal Drug Resistance

(2009) Leah E. Cowen   PLoS Pathogens

Hsp90 Governs Echinocandin Resistance in the Pathogenic Yeast Candida albicans via Calcineurin

(2009) Sheena D. Singh et al.   PLoS Pathogens

RTA2, a novel gene involved in azole resistance in Candida albicans

(2008) Xin-Ming Jia et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Changes in leukocyte migration during carbonic anhydrase activity inhibition

(2008) Hiroyoshi Kawaai et al.   BURNS

Regulation of Ceramide Biosynthesis by TOR Complex 2

(2008) Sofia Aronova et al.   Cell Metabolism

RTA2 is involved in calcineurin-mediated azole resistance and sphingoid long-chain base release in Candida albicans

(2008) X. M. Jia et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Candida infection in HIV positive patients 1985-2007

(2008) Christian Traeder et al.   MYCOSES

An integrated platform of genomic assays reveals small-molecule bioactivities

(2008) Shawn Hoon et al.   Nature Chemical Biology

The evolution of fungal drug resistance: modulating the trajectory from genotype to phenotype

(2008) Leah E. Cowen   NATURE REVIEWS MICROBIOLOGY